Australian standards of care for cystic fibrosis-related diabetes
Corresponding Author
Peter G. Middleton
CF Centre, Westmead Hospital, Sydney, New South Wales, Australia
Correspondence: Peter G. Middleton, Ludwig Engel Centre for Respiratory Research, Westmead Millennium Institute, University of Sydney, Westmead, NSW 2145, Australia. Email: [email protected]Search for more papers by this authorMonica Wagenaar
Prince Charles Hospital, Brisbane, Queensland, Australia
Search for more papers by this authorAngela G. Matson
Prince Charles Hospital, Brisbane, Queensland, Australia
Search for more papers by this authorMaria E. Craig
Sydney Children's Hospital Network (Westmead), Sydney, New South Wales, Australia
Search for more papers by this authorDeborah Jane Holmes-Walker
Department of Endocrinology, Westmead Hospital, Sydney, New South Wales, Australia
Search for more papers by this authorTamarah Katz
Sydney Children's Hospital Network, Sydney, New South Wales, Australia
Search for more papers by this authorShihab Hameed
Sydney Children's Hospital Network, Sydney, New South Wales, Australia
School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia
Search for more papers by this authorCorresponding Author
Peter G. Middleton
CF Centre, Westmead Hospital, Sydney, New South Wales, Australia
Correspondence: Peter G. Middleton, Ludwig Engel Centre for Respiratory Research, Westmead Millennium Institute, University of Sydney, Westmead, NSW 2145, Australia. Email: [email protected]Search for more papers by this authorMonica Wagenaar
Prince Charles Hospital, Brisbane, Queensland, Australia
Search for more papers by this authorAngela G. Matson
Prince Charles Hospital, Brisbane, Queensland, Australia
Search for more papers by this authorMaria E. Craig
Sydney Children's Hospital Network (Westmead), Sydney, New South Wales, Australia
Search for more papers by this authorDeborah Jane Holmes-Walker
Department of Endocrinology, Westmead Hospital, Sydney, New South Wales, Australia
Search for more papers by this authorTamarah Katz
Sydney Children's Hospital Network, Sydney, New South Wales, Australia
Search for more papers by this authorShihab Hameed
Sydney Children's Hospital Network, Sydney, New South Wales, Australia
School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia
Search for more papers by this authorAbstract
Multiple guidelines have been published over the last few years for the diagnosis and management of cystic fibrosis (CF) and cystic fibrosis related diabetes (CFRD), although some of the recommendations are based on extrapolation from other forms of diabetes and/or expert opinions. This document seeks to combine the guidelines to provide an Australian approach to the management of CFRD and establish the guidelines within the Australian CF Standards of Care.
It is intended that this document will provide assistance to doctors, nurses, dietitians, physiotherapists, diabetes educators and CF patients concerning the issues surrounding CFRD, and will be reviewed and updated in 2016.
References
- 1 Moran A, Hardin D, Rodman D, Allen HF, Beall RJ, Borowitz D, Brunzell C, Campbell PW, 3rd, Chesrown SE, Duchow C et al. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res. Clin. Pract. 1999; 45: 61–73.
- 2 Rana M, Munns CF, Selvadurai HC, Simonds S, Cooper PJ, Woodhead HJ, Hameed S, Verge CF, Lafferty AR, Crock PA et al. Increased detection of cystic-fibrosis-related diabetes in Australia. Arch. Dis. Child. 2011; 96: 823–826.
- 3 Bell SC, Bye PT, Cooper PJ, Martin AJ, McKay KO, Robinson PJ, Ryan GF, Sims GC. Cystic fibrosis in Australia, 2009: results from a data registry. Med. J. Aust. 2011; 195: 396–400.
- 4 Moran A, Becker D, Casella SJ, Gottlieb PA, Kirkman MS, Marshall BC, Slovis B, Committee CCC. Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review. Diabetes Care 2010; 33: 2677–2683.
- 5 Moran A, Brunzell C, Cohen RC, Katz M, Marshall BC, Onady G, Robinson KA, Sabadosa KA, Stecenko A, Slovis B. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care 2010; 33: 2697–2708.
- 6 O'Riordan SM, Robinson PD, Donaghue KC, Moran A. Management of cystic fibrosis-related diabetes in children and adolescents. Pediatr. Diabetes 2009; 10(Suppl. 12): 43–50.
- 7 McElduff A, Cheung NW, McIntyre HD, Lagstrom JA, Oats JJN, Ross GP, Simmons DF, Walters BNJ, Wein P. The Australasian Diabetes in Pregnancy Society consensus guidelines for the management of type 1 and type 2 diabetes in relation to pregnancy. Med. J. Aust. 2005; 183: 373–377.
- 8 Handwerger S, Roth J, Gorden P, di Sant'Agnese PA, Carpenter DF, Peter G. Glucose intolerance in cystic fibrosis. N. Engl. J. Med. 1969; 281: 451–461.
- 9 Milner AD. Blood glucose and serum insulin levels in children with cystic fibrosis. Arch. Dis. Child. 1969; 44: 351–355.
- 10 Gottlieb PA, Yu L, Babu S, Wenzlau J, Bellin M, Frohnert BI, Moran A. No relation between cystic fibrosis-related diabetes and type 1 diabetes autoimmunity. Diabetes Care 2012; 35: e57.
- 11 Blackman SM, Hsu S, Ritter SE, Naughton KM, Wright FA, Drumm ML, Knowles MR, Cutting GR. A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis. Diabetologia 2009; 52: 1858–1865.
- 12 Lanng S, Thorsteinsson B, Roder ME, Nerup J, Koch C. Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance. Clin. Endocrinol. 1994; 41: 217–223.
- 13 Marshall BC, Butler SM, Stoddard M, Moran AM, Liou TG, Morgan WJ. Epidemiology of cystic fibrosis-related diabetes. J. Pediatr. 2005; 146: 681–687.
- 14 Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am. J. Respir. Crit. Care Med. 2000; 162: 891–895.
- 15 Brennan AL, Gyi KM, Wood DM, Johnson J, Holliman R, Baines DL, Philips BJ, Geddes DM, Hodson ME, Baker EH. Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis. J. Cyst. Fibros. 2007; 6: 101–109.
- 16 Finkelstein SM, Wielinski CL, Elliott GR, Warwick WJ, Barbosa J, Wu S-C, Klein DJ. Diabetes mellitus associated with cystic fibrosis. J. Pediatr. 1988; 112: 373–377.
- 17 Milla CE, Billings J, Moran A. Diabetes is associated with dramaticly decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care 2005; 28: 2141–2144.
- 18 Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care 2009; 32: 1626–1631.
- 19 Bradbury RA, Shirkhedkar D, Glanville AR, Campbell LV. Prior diabetes mellitus is associated with increased morbidity in cystic fibrosis patients undergoing bilateral lung transplantation: an ‘orphan’ area? A retrospective case-control study. Int. Med. J. 2009; 39: 384–388.
- 20 Hameed S, Morton JR, Jaffe A, Field PI, Belessis Y, Yoong T, Katz T, Verge CF. Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain. Diabetes Care 2010; 33: 221–226.
- 21 Schiaffini R, Brufani C, Russo B, Fintini D, Migliaccio A, Pecorelli L, Bizzarri C, Lucidi V, Cappa M. Abnormal glucose tolerance in children with cystic fibrosis: the predictive role of continuous glucose monitoring system. Eur. J. Endocrinol. 2010; 162: 705–710.
- 22 Brodsky J, Dougherty S, Makani R, Rubenstein RC, Kelly A. Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis. Diabetes Care 2011; 34: 292–295.
- 23 Sterescu AE, Rhodes B, Jackson R, Dupuis A, Hanna A, Wilson DC, Tullis E, Pencharz PB. Natural history of glucose intolerance in patients with cystic fibrosis: ten-year prospective observation program. J. Pediatr. 2010; 156: 613–617.
- 24 Nankervis A, McIntyre H, Moses R, Ross G, Callaway L. Testing for gestational diabetes in Australia. Diabetes Care 2013; 35: e64.
- 25 Godbout A, Hammana I, Potvin S, Mainville D, Rakel A, Berthiaume Y, Chiasson JL, Coderre L, Rabasa-Lhoret R. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes. Diabetes Metab. 2008; 34: 568–573.
- 26 Schwarzenberg SJ, Thomas W, Olsen TW, Grover T, Walk D, Milla C, Moran A. Microvascular complications in cystic fibrosis-related diabetes. Diabetes Care 2007; 30: 1056–1061.
- 27 van den Berg JMW, Morton AM, Kok SW, Pijl H, Conway SP, Heijerman HGM. Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD). J. Cyst. Fibros. 2008; 7: 515–519.
